TRANSTHERA-B (02617.HK): H Share Full Circulation Completed

On 19 November 2026, TRANSTHERA-B (02617.HK) converted 44,971,128 unlisted shares into H shares, lifting the H share proportion to 87.70% of 408,578,633 shares.

NewTimeSpace News: On 19 November 2026, TransThera Sciences (Nanjing), Inc. (stock code: 02617.HK) said the conversion of 44,971,128 unlisted shares held by 10 participating shareholders into H shares was completed on the same day, with the converted H shares to begin trading on the Exchange at 9:00 a.m. on 20 November 2026.

Upon completion, H shares increased from 313,347,673 to 358,318,801, raising their proportion from 76.69% to 87.70%, while unlisted shares fell from 95,230,960 to 50,259,832, or from 23.31% to 12.30%. Total issued shares remain unchanged at 408,578,633.

The company had published announcements on 20 October 2025, 26 October 2026 and 1 November 2026 regarding the proposed implementation of H share full circulation, the CSRC filing notice and the Stock Exchange's listing approval.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.